Physician profile
Jonathan Read Bear
NPI 1770849523
$3,352.70
in general payments reported to CMS, 2019-2025
9 companies · $3,223 in 2025
The $3,223 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.07 · 2023: $46.18 · 2024: $61.40 · 2025: $3,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,241 · Travel and Lodging: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,240.95 |
| Travel and Lodging | $1,089.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $1,798.58 | 2023-2025 | Gammatile, Gammatile |
| Theragenics Corporation | $833.23 | 2025 | |
| Bioprotect Medical, INC. | $238.37 | 2025 | Bioprotect Balloon Implant System |
| Siemens Medical Solutions USA, INC. | $226.11 | 2024-2025 | Bravos Afterloader System |
| Blue Earth Diagnostics | $167.20 | 2024-2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $25.22 | 2025 | |
| Ge Healthcare | $24.92 | 2025 | |
| Pfizer INC. | $22.07 | 2022 | |
| Elekta, INC. | $17.00 | 2024 | Flexitron Hdr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.